Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?

Yüksel I., Cagir Y., Atay A.

Digestive and Liver Disease, vol.56, no.3, pp.530-531, 2024 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Letter
  • Volume: 56 Issue: 3
  • Publication Date: 2024
  • Doi Number: 10.1016/j.dld.2023.11.039
  • Journal Name: Digestive and Liver Disease
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Page Numbers: pp.530-531
  • Ankara Yıldırım Beyazıt University Affiliated: Yes